JAKARTA – For 27 years, Stimuno has been an integral part of the health journey for Indonesian families. Since its debut in 1999, this natural immunomodulator medication has accompanied families across generations, helping maintain strong immune systems so the body is better prepared to face various health challenges. Stimuno’s long journey is a testament to its consistency in delivering products tailored to family needs, earning lasting trust through uncompromised quality st

JAKARTA – Dexa Group is strengthening Indonesia’s national pharmaceutical ecosystem by empowering 413 farmers across 34 districts in 11 provinces to supply raw materials for medicines derived from Indonesia’s biodiversity. The Green Pharmacy initiative, one of the implementations of Dexa Group’s Right to Win strategy, has once again earned the company recognition through the detikcom Green Economy Award, in the Community Economy Appreciation category. The award recognizes Dex

Corporate reputation stems from consistent effort. It is built upon the ability to assess situations, deliver information transparently, maintain trust, and ensure that every message is grounded in accountability. This is the exact principle upheld by Dexa Group’s Corporate Communications department in supporting the company’s journey as a growing Indonesian healthcare enterprise dedicated to serving the public interest. Amidst a fast-moving communication landscape, public di

Dexa Group’s commitment to expanding healthcare access has once again been recognized. The company was honored with The Best Corporate Social Responsibility Award 2026 for Strengthening Social Solidarity and Healthcare Access Through Preventive Actions at the Indonesia Corporate Social and Environmental Responsibility Awards 2026, organized by Warta Ekonomi. The award was presented by Mr. Muhamad Ihsan, Chief Editor of Warta Ekonomi, to Mr. Mateus Ramidi, Manager of Dharma De

In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and responsible communication. For more than five decades, Dexa Group has embraced the philosophy Expertise for the Promotion of Health as the fo

Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical Products in Indonesia was presented by the Head of BPOM RI, Prof. Dr. Taruna Ikrar, to the President Director of PT Dexa Medica, Mr. V. Hery Sutanto. The award cerem

Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This award affirms Dexa Group’s consistency in safeguarding its corporate reputation through strategic, ethical, and sustainable communication

Dexa Group has once again achieved a strategic milestone by receiving the Indonesia CEO Excellence Award 2025, organized by WartaEkonomi.co.id Research and Consulting. This award recognizes visionary leadership that consistently drives business sustainability while strengthening the pharmaceutical sector’s contribution to national health resilience. The award was presented by Muhamad Ihsan, CEO & Chief Editor of WartaEkonomi.co.id, to Andy Samual, Director of Human Resources

On the occasion of the 61st National Health Day (HKN), Dexa Medica achieved a significant milestone by receiving the Karya Anak Bangsa Award from the Ministry of Health of the Republic of Indonesia, recognizing it as the pharmaceutical industry with the highest number of clinical trials for natural-based drugs in the country. The award was presented during the Health Innovation Festival (HAI-Fest) 2025 held at Kartika Expo Balai Kartini, Jakarta, on Monday, December 8, 2025.

Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies (LPH LPPOM), both official institutions for halal certification. The first recognition was the Indonesia Halal Industry Awards (IHYA) 2